The objective of this study was to validate the Functional Assessment of Cancer Therapy–Leukemia (FACT‐Leu) in patients with acute myeloid leukemia (AML) who are not candidates for intensive therapy. Click to show full abstract
The objective of this study was to validate the Functional Assessment of Cancer Therapy–Leukemia (FACT‐Leu) in patients with acute myeloid leukemia (AML) who are not candidates for intensive therapy.
               
Click one of the above tabs to view related content.